Skip to main content
Premium Trial:

Request an Annual Quote

Stanley Lapidus, Noubar Afeyan, Stephen Lombardi

Helicos shuffled some executives last week, with company co-founder and CEO Stanley Lapidus taking on the job of chairman from Noubar Afeyan and Stephen Lombardi moving up to the role of president while retaining his job as COO. Afeyan was named lead independent director on the company’s board.
 
Lombardi was previously COO and vice president of Helicos. Prior to joining the company, he was a senior VP at Affymetrix and before that he spent 16 years at Applied Biosystems as an executive in the company’s DNA sequencing and genetic analysis business.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.